1.Lavigne, JV, Gibbons, RD, Christoffel, KK, et al.Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc. 1996;32:204–214.
2.Campbell, SB. Parent-referred problem three-year-olds: developmental changes in symptoms. J Child Psychol Psychiatry. 1987;28:835–845.
3.DuPaul, GJ, McGoey, KE, Eckert, TL, VanBrakle, J. Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning. J Am Acad Child Adolesc. 2001;40:508–515.
4.Lahey, BB, Pelham, WE, Stein, MA, et al.Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc. 1998;37:695–702.
5.LaHoste, GJ, Swanson, JM, Wigal, SB, et al.Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996;1:121–124.
6.Lahey, BB, Pelham, WE, Loney, J, et al.Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4Y6 years of age. Am J Psychiatry. 2004;161:2014–2020.
7.Pierce, EW, Ewing, LJ, Campbell, SB. Diagnostic status and symptomatic behavior of hard-to-manage preschool children in middle childhood and early adolescence. J Clin Child Psychol. 1999;28:44–57.
8.Wilens, TE, Biederman, J, Brown, S, Monuteaux, M, Prince, J, Spencer, TJ. Patterns of psychopathology and dysfunction in clinically referred preschoolers. J Dev Behav Pediatr. 2002;23:S31–S36.
9.Medco Health Solutions. 2004 Drug Trend Report. Available at: www.medcohealth.com. Accessed May 17, 2004.
10.Zito, JM, Safer, DJ, dosReis, S, Gardner, JF, Boles, M, Lynch, F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283:1025–1030.
11.Kollins, S, Greenhill, L, Swanson, J, et al.Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry. 2006;45(11):1275–1283.
12.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
13.Manidiaki, K, Sonuga-Barke, E, Kakouros, E, Karaba, R. Parental beliefs about the nature of ADHD behaviours and their relationship to referral intentions in preschool children. Child Health Care Dev. 2007;33:188.
15.Consensus Development Panel. Defined Diets and Childhood Hyperactivity. National Institutes of Health Consensus Development Conference Summary. 1982; Vol 4, No 3.
16.Biederman, J, Faraone, SV, Keenan, K, Knee, D, Tsuang, MF. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990;29:526–533.
17.Faraone, SV, Biederman, J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry. 1998;44;951–958.
18.Faraone, SV, Perlis, RH, Doyle, AE, et al.Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1313–1323.
19.Kennedy, JL. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 2004;1:121–124.
20.Lowe, N, Kirley, A, Hawi, Z, et al.Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet. 2004;74:348–356.
21.McGough, JJ. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry. 2005;57:1367–1373.
22.El-Faddagh, M, Laucht, M, Maras, A, et al.Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age. J Neur Trans. 2004;111: 883–889.
23.Swanson, JM, Kraemer, HC, Hinshaw, SP, et al.Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc. 2001:40;168–179.
24.Thapar, A, Langley, K, Fowler, T, et al.Catechol o-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2005;62:1275–1278.
25.Thapar, A, Langley, K, O'Donovan, M, et al.Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Mol Psychiatry. 2006;11:714–720.
26.MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073–1086.
27.Wender, PH. ADHD: Attention-Deficit Hyperactivity Disorder in Children and Adults. Oxford University Press. 2002:9.
28.Geller, B, Williams, M, Zimerman, B, Frazier, J, Beringer, L, Warner, KL. Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect Disord. 1998;51:81–91.
29.Barkley, RA, The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc. 1998;27:336–341.
30.Cohen, NJ. Evaluation of the relative effectiveness of methylphenidate and cognitive behavior modification in the treatment of kindergarten-aged hyperactive children. J Abnormal Child Psychol. 1981;9:43–54.
31.Handen, BL, Feldman, HM, Lurier, A, Murray, PJ. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc. 1999;38:805–812.
32.Swanson, J, Greenhill, L, Wigal, T, et al.Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc. 2006;45:1304–1313.
33.Wigal, S, Gupta, S, Greenhill, L, et al.Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. In press.
34.Greenhill, L, Kollins, S, Abikoff, H, et al.Rationale, design, and methods of the preschool ADHD treatment study (PATS). J Am Acad Child Adolesc. 2006;45:11.
35.Sonuga-Barke, EJ, Daley, D, Thompson, M, Laver-Bradbury, C, Weeks, A. Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc. 2001;40:402–408.
36.Olfson, M. Diagnosing mental disorders in office-based pediatric practice. J Dev Behav Pediatr. 1992;13:363–365.
37.Frazier, T, Youngstrom, E, Glutting, J, Watkins, M. ADHD and achievement: meta-analysis of the child, adolescent, and adult literature and a concomitant study with college students. Journal of Learning Disabilities. 2007;40:49–65.
38.Bagwell, C, Molina, B, Pelham, W, Hoza, B. Attention deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 2001;40:1285–1292.
39.Pelham, W, Foster, M, Robb, J. The Economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambulatory Pediatrics. 2007;7:121–131.
40.Biederman, J, Farone, S, Milberger, S, et al.A prospective 4-year follow-up study of attention-deficit/hyperactivity and related disorders. Arch Gen Psychiatry. 1996;53:437–446.
41.Ingram, S, Hechtman, L, Morgenstern, G. Outcome issues in ADHD: adolescent and adult long-term outcome. Ment Retard Dev Disabil Res Rev. 1999;5:243–250.
42.Biederman, J, Newcorn, JH, Sprich, S. Comorbidity of attention-deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry. 1991;148:251–256.
43.Abikoff, H, Courtney, M, Pelham, WE, Koplewicz, HS. Teachers' ratings of disruptive behaviors: the influence of halo effects. J Abnorm Child Psychol. 1993;21:519–533.
44.Schachar, R, Sandber, S, Rutter, M. Agreement between teachers' ratings and observations of hyperactivity, inattentiveness and defiance. J Abnorm Child Psychol. 1986;14:331–345.
45.Pliszka, SR. Effect of anxiety on cognition, behavior and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28:882–887.
46.Rappley, MD, Gardiner, JC, Jetton, JR, Houang, RT. The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med. 1995;149:675–679.
47.Rowland, AS, Lesesne, CA, Abramowitz, AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Ret Dev Dis Res Rev. 2002;8:162–170.
49.Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.MMWR Morb Mortal Wkly Rep. 2005;54(34);842–847.
50.Wilens, T. Alcohol and other drug use and attention deficit hyperactivity disorder. Alcohol Health Res World. 1998;22:127–130.
51.Gittelman, R, Mannuzza, S, Shenker, R, Bonagura, N. Hyperactive boys almost group up: I. Psychiatric status. Arch Gen Psychiatry. 1985;42:937–947.
52.Hechtman, L, Weiss, G. Controlled prospective fifteen year follow-up of hyperactives as adults: non-medical drug and alcohol use and anti-social behaviour. Can J Psychiatry. 1986;31:557–567.
53.Barkley, R. Driving Impairments in teens and adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27:233–260.
54.Johnston, C, Mash, E. Families of children with attention deficit hyperactivity disorder: review and recommendations for future research. Clin Child Family Psychol. 2001;4:183–207.
55.Biederman, J, Wilens, T, Mick, E, et al.Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry. 1998;36:37–43.
56.Silver, LB. The relationship between learning disabilities, hperactivty, distractibility, and behavioral problems. J Am Acad Child Psychiatry. 1981;20:385–397.
57.Biederman, J, Faraone, SV, Mick, E, et al.Attention deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Psychiatry. 1996;35:997–1008.
58.Spencer, J, Biederman, J, Mick, E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambulatory Pediatrics. 2007;7:73–81.
59.Goldman, S, Genel, M, Bezman, R, Slanetz, P. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100–1107.
60.Biederman, J, Newcorn, J, Sprich, S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148:564–577.
61.Biederman, J, Faraone, SV, Milberger, S, et al.Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a 4-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry. 1996;35:1193–1204.
62.Klorman, R, Brumaghim, JT, Salzman, LF, et al.Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. J Abnorm Psychol. 1988;97:413–422.
63.Biederman, J, Faraone, SV, Keenan, K, et al.Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry. 1992;49:728–738.
64.Brent, DA, Perper, JA, Goldstein, CE, et al.Risk factors for adolescent suicide: a comparison of adolescent suicide victims with suicidal inpatients. Arch Gen Psychiatry. 1988;45:581–588.
65.Biederman, J, Faraone, S, Keenan, K, et al.Family genetic and psychosocial risk factors in attention deficit disorder. Biol Psychiatry. 1989;25:145A.
66.Morgan, A, Hynd, G, Riccio, C, Hall, J. Validity of DSM-IV ADHD predominately inattentive and combined types: relationship to previous DSM diagnoses/subtype differences. J Am Acad Child Adolsec Psychiatry. 1996;35:325–333.
67.Paternite, C, Loney, J, Roberts, M. External validation of oppositional disorder and attention deficit disorder with hyperactivity. J Abnorm Child Psychol. 1995;23:453–471.
68.Wolraich, M, Hannah, J, Pinnock, T, et al.Comparison of diagnostic criteria for attention-deficit hyperacitivty disorder in a country-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319–324.
69.Sleator, E, Ullman, R. Can the physician diagnose hyperactivity in the office? Pediatrics. 1981;67:13–17.
70.Mitsis, E, McKay, K, Schulz, K, et al.Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. Child Adolesc Psychiatry. 2000;39:308–313.
71.Molina, B, Pelham, W, Blumenthal, J, Galiszewski, E. Agreement among teachers' behavior ratings of adolescents with a childhood history of attention-deficit/hyperactivity disorder. J Clin Child Psychol. 1998;27:330–339.
72.Kramer, T, Phillips, S, hargis, M, et al.Disagreement between parent and adolescent reports of functional impairment. J Child Psychol Psychiatry. 2004;45:248–259.
74.Achenbach, T, Edelbrock, L. Manual for the Child Behavior Checklist 4-18 and 1991 Profile. Burlington, VT: University of Vermont; 1991.
75.Reynolds, C, Kamphouse, R. BASC: Behavior Assessment System for Children Manual. Circle Pines, MN: American guidance Service; 1992.
76.Brown, TE. Brown ADD Scales for Children and Adolescents. San Antonio, TX: Psychological Corp; 2001.
77.Swanson, J, Nolan, R, Pelham, W. Swanson, Nolan and Pelham Rating Scale (SNAP). Pittsburgh, PA, Department of Psychiatry, Western Psychiatric Institute and Clinic; 1998.
78.Shaffer, D, Fisher, P, Dulcan, M, et al.The second version of the NIMH Diagnostic Interview Schedule for Children (DISC-2). J Am Acad Child Adolesc Psychiatry. 1996;35:865–877.
79.Quinn, P, Wigal, S. Perceptions of girls and ADHD: results from a national survey. Med Gen Med. 2004;6:2.
80.Sharp, WS, Walter, J, Marsh, W, Ritchie, G, Hamburger, S, Castellanos, F. ADHD in girls: clinical comparability of a research sample. J Am Acad Child Adolesc Psychiatry. 1999;38:40–47.
81.Biederman, J, Faraone, S, Milberger, S, et al.Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry. 1999;38:966–975.
82.Carlson, C, Tamm, L, Gaub, M. Gender differences in children with ADHD, ODD and co-occurring ADHD/ODD identified in a school population. J Am Acad Child Adolesc Psychiatry. 1997;36:1706–1714.
83.Gaub, M, Carlson, C. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997;36:1036–1045.
84.Wigal, S, McGough, J, McCracken, J, et al.A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord. 2005;9:275:289.
85.Arnold, L. Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Ann N Y Acad Sci. 2001;931:310–341.
86.Wigal, S, Wigal, T, Kollins, S. Advances in methylphenidate drug delivery systems for ADHD therapy. Advances in ADHD. 2006;1:4–7.
87.Biederman, J, Monuteaux, M, Mick, E, et al.Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year follow-up study. Psychol Med. 2006;36:167–179.
88.Kessler, RC, Adler, L, Barkle, R, et al.the prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716–723.
89.Milstein, RB, Wilens, TE, Biederman, J, et al.Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Atten Disord. 1997;2:159–166.
90.McGough, JJ, Smalley, SL, McCracken, JT, et al.Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005;162:1621–1627.
91.Biederman, J, Faraone, SV, Spencer, T, et al.Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67:524–540.
92.Faraone, SV, Sergeant, J, Gillberg, C, et al.The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;163:716–723.
93.Borland, BL, Heckman, HK. Hyperactive boys and their brothers: a 25-year follow-up study. Arch Gen Psychiatry. 1976;33:669–675.
94.Morrison, JR. Childhood hyperactivity in an adult psychiatric population: social factors. J Clin Psychiatry. 1980;41:40–43.
95.Wilens, TE, Biederman, J, Mick, E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998;7:156–163.
96.Tarter, RE. Psychosocial history, minimal brain dysfunction and differential drinking patterns of male alcoholics. J Clin Psychol. 1982;38:867–873.
97.Murphy, K, Barkley, RA. Attention deficit hyperactivity disorder adults comorbidities and adaptive impairments. Compr Psychiatry. 1996;37:393–401.
98.Barkley, RA, Fischer, M, Fletcher, K, et al.Persistence of attention deficit hyperactivity disorder into adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279–289.
99.Weiss, M, Murray, C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ. 2003;168:715–722.
100.Barkley, RA. Major life activity and health outcomes associated with attention deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(Suppl 12):10–5.
101.Shekin, WO, Asarnow, RF, Hess, E, et al.A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry. 1990;31:416–425.
102.Biederman, J, Faraone, SV, Spencer, T, et al.Patterns of psychiatric comoribidty, cognition, and psychosocial funcitioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150:1792–1798.
103.Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset distributions fDSM-IV disorders in the national Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
104.Wilens TE: Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am. 2004;27:283–301.
105.Rush, CR, Higgins, ST, Vansickel, AR, Stoops, WW, Lile, JA, Glaser, PE. Methylphenidate increases cigarette smoking. Psychopharmacology (Berl). 2005;181:781–789.
106.Wilens, TE, Faraone, SV, Biederman, J, Gunawardene, S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;11:179–185.
107.Sobanski, E. Pschiatric comorbidity in adults with attention-deficity/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256:26–31.
108.Wender, PH, Reimherr, FW, Wood, D, Ward, M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985:142:547–552.
109.Markowitz, JS. Drug interactions with stimulant medications. Int Clin Psychopharmacol. 1999;14:1–18.
110.Greenhill, LL, Pliszka, S, Dulcan, MK, et al.Practice parameter for the use of stimulant mediaction in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry. 2002;41:26S–49S.
111.Nierenberg, AA, Mihahara, S, Spencer, T, et al.Clinical and diagnostic implications of lifetime comorbidity of attention-deficit/hyperactivity disorder in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005:57;1467–1473.
112.Brown, TE, McMullen, WJ. Attention deficit disorders and sleep/arousal disturbance. Ann NY Acad Sci. 2001;931:271–286.
113.Kooj, JJS, Huub, AM, Middelkoop, AM, Van Gils, K, Buitelaar, JK. The effect of stimulants on nocturnal activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry. 2001;62:952–955.
114.Manuzza, S, Klein, RG, Bessler, A, Malloy, P, La Padula, M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50:565–567.
115.Faraone, SV, Biederman, J, Doyle, A, et al.Neuropsychological Studies of Late Onset and Subthreshhold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry. 2006;60:1081–1087.
116.Ward, MF, Wender, PH, Reimherr, FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150:885–890.
117.Wender, PH. Attention-Deficit Hyperactivity Disorder in Adults. New York, NY: Oxford University Press; 1995.
118.Donnelly, C, Reimherr, F, Young, J. Differential diagnosis and treatment of adult ADHD and neighboring disorders. CNS Spectr. 2006;10(Suppl 11):1–16.
119.Wigal, T, Wigal, B, Steinhoff, K, et al.Establishing a clinical diagnosis of ADHD in adults: the QUEST method. Advances in ADHD. 2007. In press.
120.Safren, SA, Otto, MW, Sprich, S, Winett, CL, Wilens, TE, Biederman, J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43(7):831–842.
121.Adler, LA, Spencer, TJ, Milton, DR, et al.Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry. 2005;66:294–299.
122.Michelson, D, Adler, L, Spencer, T, et al.Atomoxetine in adults with ADHD: two randomized, placebo-controlled trials. Biol Psychiatry. 2003;53:112–120.
123.Wilens, TE. Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry. 2004;65(Suppl 3);38–45.
124.Allen, AJ, Kurlan, RM, Gilbert, DL, et al.Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005;65:1941–1949.
125.Nissen, SE. ADHD and cardiovascular risk. N Engl J Med. 2006;354:1445–1448.
126.Spencer, T, Biederman, J, Wilens, T, et al.A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:456–463.
127.Wender, EH. Managing stimulant medication for attention-deficit/hyperactivity disorder. Pediatr Rev. 2001;22:183–189.
128.Dexmethylphenidate (Focalin) for ADHD. Med Lett. 2002;44:45–46.
129.Graydanus, DE, Sloane, MA, Rappley, MD. Psychopharmacology of ADHD in adolescents. Adolesc Med. 2002;3:599–624.